Stocks in Hong Kong Spike | Sino Biopharmaceutical (01801.HK) Surges Over 4%, Mamshudupeptide Recently Approved for Listing, Commercialization to Follow Soon
According to the "China Fortune Financial and Economic APP", Sino Biopharmaceutical (01801.HK) has risen by more than 4%, as of the time of publication, it has risen by 3.66%, reaching 82.2 Hong Kong dollars, with a turnover of 6.34 billion Hong Kong dollars.
Latest
2 m ago